» Articles » PMID: 24004404

Endothelial Outgrowth Cells: Function and Performance in Vascular Grafts

Overview
Date 2013 Sep 6
PMID 24004404
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

The clinical need for vascular grafts continues to grow. Tissue engineering strategies have been employed to develop vascular grafts for patients lacking sufficient autologous vessels for grafting. Restoring a functional endothelium on the graft lumen has been shown to greatly improve the long-term patency of small-diameter grafts. However, obtaining an autologous source of endothelial cells for in vitro endothelialization is invasive and often not a viable option. Endothelial outgrowth cells (EOCs), derived from circulating progenitor cells in peripheral blood, provide an alternative cell source for engineering an autologous endothelium. This review aims at highlighting the role of EOCs in the regulation of processes that are central to vascular graft performance. To characterize EOC performance in vascular grafts, this review identifies the characteristics of EOCs, defines functional performance criteria for EOCs in vascular grafts, and summarizes the existing work in developing vascular grafts with EOCs.

Citing Articles

Endogenous bystander killing mechanisms enhance the activity of novel FAP-specific CAR-T cells against glioblastoma.

Yu W, Truong N, Polara R, Gargett T, Tea M, Pitson S Clin Transl Immunology. 2024; 13(7):e1519.

PMID: 38975278 PMC: 11225608. DOI: 10.1002/cti2.1519.


Harnessing the potential of monocytes/macrophages to regenerate tissue-engineered vascular grafts.

Das A, Smith R, Andreadis S Cardiovasc Res. 2024; 120(8):839-854.

PMID: 38742656 PMC: 11218695. DOI: 10.1093/cvr/cvae106.


The Role of Stem Cells as Therapeutics for Ischaemic Stroke.

Ya J, Pellumbaj J, Hashmat A, Bayraktutan U Cells. 2024; 13(2).

PMID: 38247804 PMC: 10814781. DOI: 10.3390/cells13020112.


Producing and Testing Prototype Tissue-Engineered 3D Tri-Leaflet Valved Stents on Biodegradable Poly-ε-Caprolactone Scaffolds.

Lutter G, Pommert N, Zhang X, Seiler J, Saeid Nia M, Meier D Int J Mol Sci. 2023; 24(24).

PMID: 38139185 PMC: 10744316. DOI: 10.3390/ijms242417357.


The effect of chronic kidney disease on tissue formation of tissue-engineered vascular grafts.

Besseling P, Krebber M, Fledderus J, Teraa M, den Ouden K, van de Kaa M APL Bioeng. 2023; 7(2):026107.

PMID: 37234843 PMC: 10208679. DOI: 10.1063/5.0138808.


References
1.
Kobayashi H, Kabuto M, Ide H, Hosotani K, Kubota T . An artificial blood vessel with an endothelial-cell monolayer. J Neurosurg. 1992; 77(3):397-402. DOI: 10.3171/jns.1992.77.3.0397. View

2.
Bryers J, Giachelli C, Ratner B . Engineering biomaterials to integrate and heal: the biocompatibility paradigm shifts. Biotechnol Bioeng. 2012; 109(8):1898-911. PMC: 3490630. DOI: 10.1002/bit.24559. View

3.
Muller W . Mechanisms of transendothelial migration of leukocytes. Circ Res. 2009; 105(3):223-30. PMC: 2739407. DOI: 10.1161/CIRCRESAHA.109.200717. View

4.
Zhang X, Xu Y, Thomas V, Bellis S, Vohra Y . Engineering an antiplatelet adhesion layer on an electrospun scaffold using porcine endothelial progenitor cells. J Biomed Mater Res A. 2011; 97(2):145-51. DOI: 10.1002/jbm.a.33040. View

5.
Klinkert P, Post P, Breslau P, van Bockel J . Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature. Eur J Vasc Endovasc Surg. 2004; 27(4):357-62. DOI: 10.1016/j.ejvs.2003.12.027. View